Director Joseph G. Flanagan resigns from GoHealth Board; Alexander Timm named lead independent director
GoHealth, Inc.
Joseph G. Flanagan resigned from Board effective June 25, 2024; served as Class II director and Chair of Nominating and Corporate Governance Committee.
Resignation not related to any disagreement with Company on operations, policies, or practices.
Alexander Timm replaces Flanagan as lead independent director.
Joseph G. Flanagan, a member of the Board of Directors (the “Board”) of GoHealth, Inc. (the “Company”), informed the Company of his intent to resign from the Board effective June 25, 2024.
Alexander Timm will replace Mr. Flanagan as lead independent director.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Joseph G. Flanagan resigned as Director at GoHealth, Inc..
Action
resigned
Role
Director
Exact text from the filing
Joseph G. Flanagan, a member of the Board of Directors (the “Board”) of GoHealth, Inc. (the “Company”), informed the Company of his intent to resign from the Board effective June 25, 2024.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.